Sumitomo Pharma Co., Ltd. (4506.T)
JPY 523.0
(0.97%)
JPY 523.0
(0.97%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 133.36 Billion JPY | -45.37% |
| 2022 | 244.12 Billion JPY | 0.07% |
| 2021 | 243.96 Billion JPY | -7.54% |
| 2020 | 263.85 Billion JPY | 954.59% |
| 2019 | 25.02 Billion JPY | -10.58% |
| 2018 | 27.98 Billion JPY | -9.57% |
| 2017 | 30.94 Billion JPY | 209.4% |
| 2016 | 10 Billion JPY | -64.29% |
| 2015 | 28 Billion JPY | -44.0% |
| 2014 | 50 Billion JPY | -41.18% |
| 2013 | 85 Billion JPY | -10.53% |
| 2012 | 95 Billion JPY | -19.49% |
| 2011 | 118 Billion JPY | 26.88% |
| 2010 | 93 Billion JPY | 0.0% |
| 2009 | - JPY | 0.0% |
| 2008 | - JPY | 0.0% |
| 2007 | - JPY | -100.0% |
| 2006 | 4.6 Billion JPY | -12.81% |
| 2005 | 5.27 Billion JPY | -24.63% |
| 2004 | 7 Billion JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 133.39 Billion JPY | 0.02% |
| 2024 Q2 | 133.43 Billion JPY | 0.02% |
| 2023 FY | 133.36 Billion JPY | -45.37% |
| 2023 Q2 | 244.21 Billion JPY | 0.02% |
| 2023 Q3 | 184.25 Billion JPY | -24.55% |
| 2023 Q4 | 133.36 Billion JPY | -27.62% |
| 2023 Q1 | 244.17 Billion JPY | 0.02% |
| 2022 Q2 | 244.04 Billion JPY | 0.02% |
| 2022 Q1 | 244 Billion JPY | 0.02% |
| 2022 FY | 244.12 Billion JPY | 0.07% |
| 2022 Q4 | 244.12 Billion JPY | 0.02% |
| 2022 Q3 | 244.08 Billion JPY | 0.02% |
| 2021 Q3 | 243.96 Billion JPY | 0.0% |
| 2021 Q4 | 243.96 Billion JPY | 0.0% |
| 2021 FY | 243.96 Billion JPY | -7.54% |
| 2021 Q1 | 263.16 Billion JPY | -0.26% |
| 2021 Q2 | 243.96 Billion JPY | -7.3% |
| 2020 Q3 | 264.56 Billion JPY | 88.34% |
| 2020 Q2 | 140.47 Billion JPY | 478.55% |
| 2020 FY | 263.85 Billion JPY | 954.59% |
| 2020 Q1 | 24.28 Billion JPY | -2.96% |
| 2020 Q4 | 263.85 Billion JPY | -0.26% |
| 2019 FY | 25.02 Billion JPY | -10.58% |
| 2019 Q4 | 25.02 Billion JPY | -2.79% |
| 2019 Q3 | 25.73 Billion JPY | -2.88% |
| 2019 Q2 | 26.5 Billion JPY | -2.72% |
| 2019 Q1 | 27.24 Billion JPY | -2.64% |
| 2018 Q1 | 30.2 Billion JPY | -2.39% |
| 2018 Q4 | 27.98 Billion JPY | -2.58% |
| 2018 Q3 | 28.72 Billion JPY | -2.51% |
| 2018 FY | 27.98 Billion JPY | -9.57% |
| 2018 Q2 | 29.46 Billion JPY | -2.45% |
| 2017 Q2 | - JPY | -100.0% |
| 2017 Q1 | 10 Billion JPY | 0.0% |
| 2017 FY | 30.94 Billion JPY | 209.4% |
| 2017 Q4 | 30.94 Billion JPY | -0.19% |
| 2017 Q3 | 31 Billion JPY | 0.0% |
| 2016 Q4 | 10 Billion JPY | -50.0% |
| 2016 Q1 | 28 Billion JPY | 0.0% |
| 2016 Q2 | 20 Billion JPY | -28.57% |
| 2016 FY | 10 Billion JPY | -64.29% |
| 2016 Q3 | 20 Billion JPY | 0.0% |
| 2015 Q2 | 28 Billion JPY | -44.0% |
| 2015 FY | 28 Billion JPY | -44.0% |
| 2015 Q3 | 28 Billion JPY | 0.0% |
| 2015 Q4 | 28 Billion JPY | 0.0% |
| 2015 Q1 | 50 Billion JPY | 0.0% |
| 2014 Q3 | 80.37 Billion JPY | 0.32% |
| 2014 Q2 | 80.11 Billion JPY | -3.1% |
| 2014 Q1 | 82.67 Billion JPY | -2.73% |
| 2014 FY | 50 Billion JPY | -41.18% |
| 2014 Q4 | 50 Billion JPY | -37.79% |
| 2013 Q1 | 92.5 Billion JPY | -2.63% |
| 2013 Q3 | 87.5 Billion JPY | -2.78% |
| 2013 FY | 85 Billion JPY | -10.53% |
| 2013 Q4 | 85 Billion JPY | -2.86% |
| 2013 Q2 | 90 Billion JPY | -2.7% |
| 2012 FY | 95 Billion JPY | -19.49% |
| 2012 Q2 | 113 Billion JPY | -2.16% |
| 2012 Q3 | 110.5 Billion JPY | -2.21% |
| 2012 Q1 | 115.5 Billion JPY | -2.12% |
| 2012 Q4 | 95 Billion JPY | -14.03% |
| 2011 FY | 118 Billion JPY | 26.88% |
| 2011 Q1 | 90.5 Billion JPY | -2.69% |
| 2011 Q3 | 120.5 Billion JPY | -2.03% |
| 2011 Q2 | 123 Billion JPY | 35.91% |
| 2011 Q4 | 118 Billion JPY | -2.07% |
| 2010 Q3 | 45.5 Billion JPY | 0.0% |
| 2010 Q4 | 93 Billion JPY | 104.4% |
| 2010 Q2 | - JPY | 0.0% |
| 2010 Q1 | - JPY | 0.0% |
| 2010 FY | 93 Billion JPY | 0.0% |
| 2009 Q3 | 600 Million JPY | -33.33% |
| 2009 FY | - JPY | 0.0% |
| 2009 Q4 | - JPY | -100.0% |
| 2009 Q2 | 900 Million JPY | 0.0% |
| 2008 Q4 | - JPY | 0.0% |
| 2008 FY | - JPY | 0.0% |
| 2007 FY | - JPY | -100.0% |
| 2006 FY | 4.6 Billion JPY | -12.81% |
| 2005 FY | 5.27 Billion JPY | -24.63% |
| 2004 FY | 7 Billion JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 1.23 Billion JPY | -10734.037% |
| Takeda Pharmaceutical Company Limited | 4476.5 Billion JPY | 97.021% |
| Shionogi & Co., Ltd. | 8.75 Billion JPY | -1423.672% |
| Wakamoto Pharmaceutical Co.,Ltd. | - JPY | -Infinity% |
| Nippon Shinyaku Co., Ltd. | 1.15 Billion JPY | -11476.997% |
| Kaken Pharmaceutical Co., Ltd. | - JPY | -Infinity% |
| Eisai Co., Ltd. | 134.77 Billion JPY | 1.043% |
| Morishita Jintan Co., Ltd. | 106 Million JPY | -125717.925% |
| Hisamitsu Pharmaceutical Co., Inc. | 76 Million JPY | -175382.895% |
| Mochida Pharmaceutical Co., Ltd. | - JPY | -Infinity% |
| Fuso Pharmaceutical Industries,Ltd. | 7.02 Billion JPY | -1799.544% |
| Nippon Chemiphar Co., Ltd. | 13.34 Billion JPY | -899.453% |
| Tsumura & Co. | 54.37 Billion JPY | -145.264% |
| Kissei Pharmaceutical Co., Ltd. | - JPY | -Infinity% |
| Torii Pharmaceutical Co., Ltd. | 22 Million JPY | -606113.636% |
| Towa Pharmaceutical Co., Ltd. | 189.12 Billion JPY | 29.482% |
| Fuji Pharma Co., Ltd. | 11.92 Billion JPY | -1018.475% |
| Zeria Pharmaceutical Co., Ltd. | 7.94 Billion JPY | -1578.882% |
| KYORIN Holdings, Inc. | 435 Million JPY | -30559.08% |
| Taiko Pharmaceutical Co.,Ltd. | 2.74 Billion JPY | -4765.633% |
| Daito Pharmaceutical Co.,Ltd. | 4.66 Billion JPY | -2756.436% |
| SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
| MedRx Co., Ltd | - JPY | -Infinity% |
| Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
| Solasia Pharma K.K. | 27 Million JPY | -493851.852% |
| Modalis Therapeutics Corporation | 412.5 Million JPY | -32231.394% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 4.5 Billion JPY | -2860.422% |
| Sawai Group Holdings Co., Ltd. | 66.84 Billion JPY | -99.529% |
| Cyfuse Biomedical K.K. | 345 Million JPY | -38557.101% |
| Toho Holdings Co., Ltd. | 28.16 Billion JPY | -373.504% |
| Koa Shoji Holdings Co.,Ltd. | 1.59 Billion JPY | -8280.567% |